References
- ReimundePRodicioCLopezNAlonsoADevesaPDevesaJEffects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsyTher Clin Risk Manag2010658559221151628
- JohnstonMVPlasticity in the developing brain: implications for rehabilitationDev Disabil Res Rev20091529410119489084
- Krageloh-MannICansCCerebral palsy updateBrain Dev200931753754419386453
- Kerem GunelMRehabilitation of children with cerebral palsy from a physiotherapist’s perspectiveActa Orthop Traumatol Turc200943217318019448358
- DevesaJCasteleiroNRodicioCLopezNReimundePGrowth hormone deficiency and cerebral palsyTher Clin Risk Manag2010641341820856687
- ShimMLMoshangTJrOppenheimWLCohenPIs treatment with growth hormone effective in children with cerebral palsy?Dev Med Child Neurol200446856957115287249
- AbergNDBryweKGIsgaardJAspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brainScientific World Journal2006186538016432628
- DevesaJDevesaPReimundePGrowth hormone revisitedMed Clin (Barc)20101351466567020045134
- DevesaPReimundePGallegoRDevesaJArceVMGrowth hormone (GH) treatment may cooperate with locally-produced GH in increasing the proliferative response of hippocampal progenitors to kainate-induced injuryBrain Inj201125550351021456999
- ReimundePQuintanaACastanonBEffects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injuryBrain Inj2011251657321117918
- PalisanoRRosenbaumPWalterSRussellDWoodEGaluppiBDevelopment and reliability of a system to classify gross motor function in children with cerebral palsyDev Med Child Neurol19973942142239183258
- NewborgJStockJRWnekLSpanish adaptationCruz LópezMVGonzález CriadoMBattelle: Inventario de desarrollo1st edMadridTEA Ediciones1996
- NewborgJStockJRWnekLBattelle Developmental Inventory with Recalibrated Technical Data and Norms: Screening Test Examiner’s Manual2nd edAllen, TXDLM, Inc1988
- Brooks-GunnJMcCartonCMCaseyPHEarly intervention in low-birth-weight premature infants. Results through age 5 years from the Infant Health and Development ProgramJAMA199427216125712627933370
- McCartonCMBrooks-GunnJWallaceIFResults at age 8 years of early intervention for low-birth-weight premature infants. The Infant Health and Development ProgramJAMA199727721261328990337
- SpittleAJOrtonJDoyleLWBoydREarly developmental intervention programs post hospital discharge to prevent motor and cognitive impairments in preterm infantsCochrane Database Syst Rev200722CD00549517443595
- ConiglioSJStevensonRDGrowth hormone deficiency in two children with cerebral palsyDev Med Child Neurol19953711101310158566448
- AliOShimMFowlerEGrowth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot studyJ Clin Endocrinol Metab200792393293717179200
- Puga GonzálezBFerrández LongásAOyarzábalMNosasRGrupo Colaborativo EspañolThe effects of growth hormone deficiency and growth hormone replacement therapy on intellectual ability, personality and adjustment in childrenPediatr Endocrinol Rev20107432833820684123
- ScheepensAWilliamsCEBreierBHGuanJGluckmanPDA role for the somatotropic axis in neural development, injury and diseaseJ Pediatr Endocrinol Metab200013Suppl 61483149111202225
- AbergNDJohanssonIAbergMAPeripheral administration of GH induces cell proliferation in the brain of adult hypophysectomized ratsJ Endocrinol2009201114115019171566
- ChristophidisLJGorbaTGustavssonMGrowth hormone receptor immunoreactivity is increased in the subventricular zone of juvenile rat brain after focal ischemia: A potential role for growth hormone in injury-induced neurogenesisGrowth Horm IGF Res200919649750619524466
- GasperiMCastellanoAEGrowth hormone/insulin-like growth factor I axis in neurodegenerative diseasesJ Endocrinol Invest201033858759120930497
- DevesaJLimaLTresguerresJANeuroendocrine control of growth hormone secretion in humansTrends Endocrinol Metab19923517518318407098
- DevesaJArceVLoisNTresguerresJALimaLAlpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal menJ Clin Endocrinol Metab1990716158115881977761
- GleesonHBarretoESSalvatoriRMetabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated deficiency due to a GHRH receptor mutationClin Endocrinol (Oxf)200766446647417371461
- LanesRPaoliMCarrilloEVillaroelOPalaciosACardiovascular risk of young growth-hormone-deficient adolescents. Differences in growth-hormone-treated and untreated patientsHorm Res200360629129614646407